Navigation Links
Mediware to Report Third Quarter 2008 Financial Results on Tuesday, May 6th
Date:4/29/2008

Conference Call Scheduled For May 6th At 10:00 am ET, 9:00 am CT

LENEXA, Kan., April 29 /PRNewswire-FirstCall/ -- Mediware Information Systems, Inc. (Nasdaq: MEDW) will release its financial results for the third quarter of fiscal year 2008 on Tuesday, May 6th. The Company will host a teleconference call at 10:00 am Eastern Time (9:00 am Central Time) that day to discuss the results. There will be a question-and-answer session directly following the presentation of the results.

To participate in the teleconference, please call toll-free 888-869-1189 (direct dial 706-643-5902) five minutes before the scheduled start in order to register for the call. The conference ID is: 44903038. You may also register in advance of the call online by going to: http://www.directeventreg.com/registration/event/44903038.

A replay of the call will be available after the call's completion for 5 days at 800-642-1687 (direct dial 706-645-9291). The conference ID is 44903038. After 5 days, the replay will be available on the company's web site: http://www.mediware.com.

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware's products and services, visit the company's web site at http://www.mediware.com.

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.

Contact: John Van Blaricum Thomas Redington

VP, Marketing & Communications 203 222-7399

913 307-1017 212 926-1733

http://www.mediware.com http://www.redingtoninc.com


'/>"/>
SOURCE Mediware Information Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Mediware Board Authorizes $4 Million Stock Buyback
2. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
3. Replidyne to Report First Quarter 2008 Earnings
4. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
5. SuperGen Reports 2008 First Quarter Financial Results
6. Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
7. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
8. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
9. CV Therapeutics Reports 2008 First Quarter Financial Results
10. Caliper Life Sciences Reports West Coast Consolidation of Operations
11. Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... The global chronic kidney disease ... by Transparency Market Research (TMR). The top four players, ... Inc., accounted for a share of only 41.4% in ... market are focusing aggressively on mergers, acquisitions, and strategic ... to lead to market consolidation in the next few ...
(Date:3/22/2017)... 2017   Boston Biomedical , an industry leader ... target cancer stemness pathways, today announced its Board of ... Chief Executive Officer, effective April 24, 2017. ... , M.D., FACP, who has led Boston Biomedical since ... leadership, Boston Biomedical has grown from a "garage startup" ...
(Date:3/22/2017)... Freeport, Grand Bahama (PRWEB) , ... March 21, 2017 , ... ... a free educational seminar as part of their live events series, “Stem Cell Therapy: ... adult stem cell facility under the 2013 Stem Cell Research and Therapy Act, ...
(Date:3/22/2017)... , ... March 21, 2017 , ... ... , more than tripling its goal and raising over $30,000 in the first ... that grows nutritious veggies & herbs fast, easy, and affordably, anywhere. , “Simply ...
Breaking Biology Technology:
(Date:3/7/2017)... CITY , March 7, 2017   HireVue ... help top global companies identify the best talent, faster, ... as Chief Sales Officer (CSO) and Diana Kucer ... appointments round out a seasoned executive team poised to drive ... beyond, building on a year of record bookings in ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
(Date:3/2/2017)... March 2, 2017 Who risk to be ... Download the full report: https://www.reportbuyer.com/product/4313699/ WILL ... SENSOR FIELD? Fingerprint sensors using capacitive technology represent ... sensor vendor Idex forecasts an increase of 360% of ... and of the fingerprint sensor market between 2014 and ...
Breaking Biology News(10 mins):